A Phase 1, Randomized, Open-Label Crossover Study to Evaluate the Safety and Pharmacokinetics of 400 Mg Albaconazole Administered to Healthy Participants as a Tablet Formulation Versus a Capsule Formulation

Clinical Pharmacology: Advances and Applications - New Zealand
doi 10.2147/cpaa.s39600
Full Text
Abstract

Available in full text

Categories
Pharmacology
Date
Authors
Publisher

Informa UK Limited


Related search